Pelvic inflammatory disease: The importance of aggressive treatment in adolescents

Cleveland Clinic Journal of Medicine

Volumn 65, Issue 7, 1998, Pages 369-376

  Rome, Ellen S ^a,b,c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTETAN; CEFOXITIN; CIPROFLOXACIN; CLINDAMYCIN; DOXYCYCLINE; GENTAMICIN; METRONIDAZOLE; OFLOXACIN; SULTAMICILLIN;

ADOLESCENT; BACTEROIDES; CHLAMYDIA TRACHOMATIS; ECHOGRAPHY; FEMALE; FEMALE INFERTILITY; GARDNERELLA VAGINALIS; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LAPAROSCOPY; MENSTRUATION; NEISSERIA GONORRHOEAE; ORAL DRUG ADMINISTRATION; PELVIC INFLAMMATORY DISEASE; PELVIS PAIN SYNDROME; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; TUBOOVARIAN ABSCESS; VAGINITIS;

EID: 0031880001     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.65.7.369     Document Type: Review

References (37)

1. Centers for Disease Control and Prevention. 1998 Guidelines for treatment of sexually transmitted diseases. MMWR 1998; 47(RR-1):1-116.
2. Sweet RL. Role of bacterial vaginosis in pelvic inflammatory disease. Clin Infect Dis 1995; 20(Suppl 2):S271-S275.
3. Burnakis TG, Hildebrandt NB. Pelvic inflammatory disease: a review with emphasis on antimicrobial therapy. Rev Infect Dis 1986; 8:86-116.
4. Washington AE, Katz P. Cost of and payment source for pelvic inflammatory disease. JAMA 1991; 266:2565-2569.
5. Westrom L. Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Am J Obstet Gynecol 1980; 138:880-892.
6. Rome ES. Pelvic inflammatory disease in the adolescent. Curr Opin Pediatr 1994; 6:383-387.
7. Washington AE, Aral SO, Wolner-Hanssen P, Grimes DA, Holmes KK. Assessing risk for pelvic inflammatory disease and its sequelae. JAMA 1991; 266:2581-2586.
8. Scholes D, Daling JR, Stergachis A, et al. Vaginal douching as a risk factor for acute pelvic inflammatory disease. Obstet Gynecol 1993; 81:601-606.
9. Wolner-Hanssen P, Eschenbach DA, Paavonen J, et al. Association between vaginal douching and acute pelvic inflammatory disease. JAMA 1990; 263:1936-1941.
10. Forrest KA, Washington AE, Daling JR, Sweet RL. Vaginal douching as a possible risk factor for PID. J Natl Med Assoc 1989; 81:159-165.
11. Westrom L, Bengtsson LP, Mardh PA. The risk of pelvic inflammatory disease in women using intrauterine contraceptive devices as compared to non-users. Lancet 1976; 2:221-224.
12. Grimes DA. Intrauterine devices and pelvic inflammatory disease: recent developments. Contraception 1987; 36:97-109.
13. Bromham DR. Intrauterine contraceptive devices: a reappraisal. Br Med Bull 1993; 49:100-123.
14. Burkman RT. Association between intrauterine device and pelvic inflammatory disease. Obstet Gynecol 1981; 57:269-276.
15. Zorlu CG, Aral K, Cobanoglu O, Gurler S, Gokmen O. Pelvic inflammatory disease and intrauterine devices: prophylactic antibiotics to reduce febrile complications. Adv Contraception 1993; 9:299-302.
16. Hingson RW, Strunin L, Berlin BM, Heeren T. Beliefs about AIDS, use of alcohol and drugs, and unprotected sex among Massachusetts adolescents. Am J Public Health 1990; 80:295-299.
17. DiClemente RJ, Durbin M, Siegel D, Krasnovsky F, Lazarus N. Determinants of condom use among junior high school students in a minority, inner-city school district. Pediatrics 1992; 89:197-202.
18. Shafer MA. Sexually transmitted disease syndromes. In: McAnarney ER, Kreipe RE, Orr DP, and Comerci GD, editors. Textbook of Adolescent Medicine. Philadelphia: W.B. Saunders Company, 1992:703-705.
19. Sweet RL. Diagnosis and treatment of acute salpingitis. J Reprod Med 1977; 19:21-30.
20. Paavonen J, Teisala K, Heinonen PK, et al. Microbiological and histopathological findings in acute pelvic inflammatory disease. Br J Obstet Gynaecol 1987; 94:454-460.
21. Hillier SL, Kiviat NB, Critchlow C, et al. Bacterial vaginosis-associated bacteria as etiologic agents of pelvic inflammatory disease (abstract). Proceedings of the annual meeting of the Infectious Diseases Society of Obstetrics and Gynecology (San Diego), 1992.
22. Eschenbach DA, Hillier S, Critchlow C, et al. Diagnosis and clinical manifestations of bacterial vaginosis. Am J Obstet Gynecol 1988; 158:819-828.
23. Spence MR, Adler J, McLellan R. Pelvic inflammatory disease in the adolescent. J Adolesc Health Care 1990; 4:304-309.
24. Sweet RL. Pelvic inflammatory disease and infertility in women. Infect Dis Clin North Am 1987; 1:199-215.
25. Jacobson L, Westrom L. Objectivized diagnosis of acute pelvic inflammatory disease. Am J Obstet Gynecol 1969; 105:1088-1098.
26. Centers for Disease Control and Prevention. Pelvic inflammatory disease. MMWR 1993; 42:75-81.
27. Hillis SD, Joesoef R, Marchbanks PA, et al. Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility. Am J Obstet Gynecol 1993; 168:1503-1509.
28. Slap GB, Forke CM, Cnaan A, et al. Recognition of tubo-ovarian abscess in adolescents with pelvic inflammatory disease. J Adolesc Health 1996; 18:397-403.
29. Golden NH, Cohen H, Gennari G, et al. The use of pelvic ultrasonography in the evaluation of adolescents with pelvic inflammatory disease. AJDC 1987; 141:1235-1238.
30. Cacciatore B, Leminen A, Ingman-Friberg S, Ylostalo P, Paavonen J. Transvaginal sonographic findings in ambulatory patients with suspected pelvic inflammatory disease. Obstet Gynecol 1992; 80:912-916.
31. Centers for Disease Control and Prevention. 1993 Guidelines for treatment of sexually transmitted disease. MMWR 1993; 42(RR-14):75-81.
32. Rome ES, Moszczenski SA, Craighill MC, et al. An inpatient clinical pathway for pelvic inflammatory disease. Clinical Performance and Quality Health Care 1995; 3:185-196.
33. US Department of Health and Human Services, Public Health Service. For a healthy nation: returns on investment in public health. The Joint Council of Governmental Public Health Agencies, 1994.
34. Haddix AC, Hillis SD, Kassler WJ. The cost-effectiveness of azithromycin for Chlamydia trachomatis infections in women. Sexually Transmitted Diseases 1995; 22:274-280.
35. Martin DH, Mroczkowski TF, Dalu ZA, et al. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. N Engl J Med 1992; 327:921-925.
36. Hammerschklag MR, Golden NH, Oh MK, et al. Single dose of azithromycin for the treatment of genital chlamydial infections in adolescents. J Pediatr 1993; 122:961-965.
37. Hessol NA, Priddy FH, Bolan G, et al. Management of pelvic inflammatory disease by primary care physicians. A comparison with Centers for Disease Control and Prevention guidelines. Sexually Transmitted Diseases 1996; 23:157-163.